Skip to content

Roger D Weiss

5 papers in the library · 30 citations · publishing 2009-2025

Papers

Sort Most recent Most cited

Modulating mechanisms of adverse childhood experiences in a mindfulness-based intervention: preliminary insights from an opioid use disorder study.

Frontiers in Psychology 2025 Diane Joss, Joseph Rosansky, Paula Gardiner et al. 1 citation

Adverse childhood experiences (ACE) are transdiagnostic developmental risk factors for various mental and physical health issues, including Opioid Use Disorder (OUD). Existing research demonstrated ACE not only affects the onset, severity, and comorbidity of disorders, but also affects treatment responses. To investigate whether and how ACE modulates treatment effects of Mindfulness Based...

Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment

JAMA Network Open 2025 Zev Schuman-Olivier, Hannah J. Goodman, Joseph Rosansky et al.

Key Points Question During buprenorphine treatment, does group-based mindfulness training reduce opioid use, craving, and anxiety compared with group recovery support? Findings In this randomized clinical trial including 196 adults prescribed buprenorphine for opioid use disorder, mindfulness was not superior at reducing illicit opioid use compared with an active group intervention with an...

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.

JAMA Psychiatry 2023 Brian D Kiluk, Bethea A Kleykamp, Sandra D Comer et al. 22 citations

Novel treatments for opioid use disorder (OUD) are needed to address both the ongoing opioid epidemic and long-standing barriers to existing OUD treatments that target the endogenous μ-opioid receptor (MOR) system. The goal of this review is to highlight unique clinical trial design considerations for the study of emerging treatments for OUD that address targets beyond the MOR system. In...

Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.

Drug and Alcohol Dependence June 4, 2009 Li-Tzy Wu, Christopher L. Ringwalt, Roger D Weiss et al.

Aims: To present the prevalence and correlates of hallucinogen use disorders (HUDs: abuse or dependence) and subthreshold dependence. Methods: The study sample included adolescents aged 12-17 years (N=55,286) who participated in the National Survey on Drug Use and Health (2004-2006). Data were collected with a combination of computer-assisted personal interviewing and audio computer-assisted...

DOI: 10.1016/j.drugalcdep.2009.04.014 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders N-methyl-3,4-methylenedioxyamphetamine Hallucinogens +9